Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Swiss Market Performance
7D7 Days: -1.1%
3M3 Months: -2.0%
1Y1 Year: 3.1%
YTDYear to Date: 2.0%
Over the last 7 days, the market has dropped 1.1%, driven by a loss of 1.4% in the Healthcare sector. As for the longer term, the market has actually risen by 3.1% in the last year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.